Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 6/2013

01-11-2013 | Original Article

The brain in late-onset glycogenosis II: a structural and functional MRI study

Authors: Barbara Borroni, M. S. Cotelli, E. Premi, S. Gazzina, M. Cosseddu, A. Formenti, R. Gasparotti, M. Filosto, A. Padovani

Published in: Journal of Inherited Metabolic Disease | Issue 6/2013

Login to get access

Abstract

Background

Late-onset glycogenosis type II (GSD II) is a rare, multisystem disorder mainly affecting limb and respiratory muscles due to acid alpha glucosidase deficiency. Despite evidence at autopsy of glycogen accumulation in the brain, no study exploring brain functions is yet available.

Objective

Our objective in this study was to assess brain changes in late-onset GSD II.

Methods

Each patient underwent a standardized neuropsychological assessment, regional grey-matter (GM) atrophy, and resting-state functional magnetic resonance imaging (RS-fMRI). Functional connectivity maps of the salience (SN) and default-mode (DMN) networks were considered. A group of age- and gender-matched healthy controls was enrolled for MRI comparisons. P values family-wise error (FWE) cluster level corrected inferior to 0.05 were considered.

Results

Nine GSD II patients (age 46.6 ± 8.0; 55 % male) were recruited. No significant GM atrophy was found in patients compared with controls (n = 18; age 48.0 ± 9.8,;40 % male). Functional connectivity within the SN was selectively reduced in patients, and cingulate gyrus and medial frontal cortex were mainly involved. Accordingly, patients had significant impairment of executive functions (as measured by Wisconsin Card Sorting test), whereas other cognitive domains were within mean normal ranges.

Conclusions

Our findings extend the clinical spectrum of GSD II by indicating that brain changes occur in this muscular disorder. Above all, these results should lead to better examinations of therapeutic approaches and perspectives for the affected patients. Further studies evaluating in depth these issues are warranted.
Literature
go back to reference American Association of Neuromuscular & Electrodiagnostic Medicine (2009) Diagnostic criteria for late-onset (childhood and adult) Pompe disease. Muscle Nerve 40:149–160CrossRef American Association of Neuromuscular & Electrodiagnostic Medicine (2009) Diagnostic criteria for late-onset (childhood and adult) Pompe disease. Muscle Nerve 40:149–160CrossRef
go back to reference Angelini C, Semplicini C, Ravaglia S et al (2012) Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. J Neurol 259:952–958PubMedCrossRef Angelini C, Semplicini C, Ravaglia S et al (2012) Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. J Neurol 259:952–958PubMedCrossRef
go back to reference Ashburner J, Friston KJ (2001) Why voxel-based morphometry should be used. NeuroImage 14:1238–1243PubMedCrossRef Ashburner J, Friston KJ (2001) Why voxel-based morphometry should be used. NeuroImage 14:1238–1243PubMedCrossRef
go back to reference Begley DJ, Pontikis CC, Scarpa M (2008) Lysosomal storage diseases and the blood–brain barrier. Curr Pharm Des 14:1566–1580PubMedCrossRef Begley DJ, Pontikis CC, Scarpa M (2008) Lysosomal storage diseases and the blood–brain barrier. Curr Pharm Des 14:1566–1580PubMedCrossRef
go back to reference Bembi B, Cerini E, Danesino C et al (2008) Diagnosis of glycogenosis type II. Neurology 71:S4–S11PubMedCrossRef Bembi B, Cerini E, Danesino C et al (2008) Diagnosis of glycogenosis type II. Neurology 71:S4–S11PubMedCrossRef
go back to reference Berg EA (1948) A simple objective technique for measuring flexibility in thinking. J Gen Psychol 39:15–22PubMedCrossRef Berg EA (1948) A simple objective technique for measuring flexibility in thinking. J Gen Psychol 39:15–22PubMedCrossRef
go back to reference Borroni B, Alberici A, Premi E et al (2008) Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers. Rejuvenation Res 11:585–595PubMedCrossRef Borroni B, Alberici A, Premi E et al (2008) Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers. Rejuvenation Res 11:585–595PubMedCrossRef
go back to reference Braunsdorf WE (1987) Fusiform aneurysm of basilar artery and ectatic internal carotid arteries associated with glycogenosis type 2 (Pompe’s disease). Neurosurgery 21:748–749PubMedCrossRef Braunsdorf WE (1987) Fusiform aneurysm of basilar artery and ectatic internal carotid arteries associated with glycogenosis type 2 (Pompe’s disease). Neurosurgery 21:748–749PubMedCrossRef
go back to reference Capitani E, Laiacona M (1997) Composite neuropsychological batteries and demographic correction: standardization based on equivalent scores, with a review of published data. The Italian Group for the Neuropsychological Study of Ageing. J Clin Exp Neuropsychol 19:795–809PubMedCrossRef Capitani E, Laiacona M (1997) Composite neuropsychological batteries and demographic correction: standardization based on equivalent scores, with a review of published data. The Italian Group for the Neuropsychological Study of Ageing. J Clin Exp Neuropsychol 19:795–809PubMedCrossRef
go back to reference Chien YH, Lee NC, Peng SF, Hwu WL (2006) Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy. Pediatr Res 60:349–352PubMedCrossRef Chien YH, Lee NC, Peng SF, Hwu WL (2006) Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy. Pediatr Res 60:349–352PubMedCrossRef
go back to reference Craig AD (2002) How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 3(8):655–666PubMed Craig AD (2002) How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 3(8):655–666PubMed
go back to reference Craig AD (2009) Emotional moments across time: a possible neural basis for time perception in the anterior insula. Philos Trans R Soc Lond B Biol Sci 364(1525):1933–1942PubMedCrossRef Craig AD (2009) Emotional moments across time: a possible neural basis for time perception in the anterior insula. Philos Trans R Soc Lond B Biol Sci 364(1525):1933–1942PubMedCrossRef
go back to reference De Luca M, Beckmann CF, De SN, Matthews PM, Smith SM (2006) fMRI resting state networks define distinct modes of long-distance interactions in the human brain. NeuroImage 29:1359–1367PubMedCrossRef De Luca M, Beckmann CF, De SN, Matthews PM, Smith SM (2006) fMRI resting state networks define distinct modes of long-distance interactions in the human brain. NeuroImage 29:1359–1367PubMedCrossRef
go back to reference Di Rocco M, Buzzi D, Taro M (2007) Glycogen storage disease type II: clinical overview. Acta Myol 26:42–44PubMed Di Rocco M, Buzzi D, Taro M (2007) Glycogen storage disease type II: clinical overview. Acta Myol 26:42–44PubMed
go back to reference Dineen RA, Vilisaar J, Hlinka J et al (2009) Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 132:239–249PubMedCrossRef Dineen RA, Vilisaar J, Hlinka J et al (2009) Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 132:239–249PubMedCrossRef
go back to reference Ebbink BJ, Aarsen FK, van Gelder CM et al (2012) Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy. Neurology 78:1512–1518PubMedCrossRef Ebbink BJ, Aarsen FK, van Gelder CM et al (2012) Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy. Neurology 78:1512–1518PubMedCrossRef
go back to reference Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef
go back to reference Fox MD, Raichle ME (2007) Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci 8:700–711PubMedCrossRef Fox MD, Raichle ME (2007) Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci 8:700–711PubMedCrossRef
go back to reference Greicius MD, Krasnow B, Reiss AL, Menon V (2003) Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A 100:253–258PubMedCrossRef Greicius MD, Krasnow B, Reiss AL, Menon V (2003) Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A 100:253–258PubMedCrossRef
go back to reference Isaacs B, Kennie AT (1973) The set test as an aid to the detection of dementia in old people. Br J Psychiatry 123:467–470PubMedCrossRef Isaacs B, Kennie AT (1973) The set test as an aid to the detection of dementia in old people. Br J Psychiatry 123:467–470PubMedCrossRef
go back to reference Jack RM, Gordon C, Scott CR, Kishnani PS, Bali D (2006) The use of acarbose inhibition in the measurement of acid alpha-glucosidase activity in blood lymphocytes for the diagnosis of Pompe disease. Genet Med 8:307–312PubMedCrossRef Jack RM, Gordon C, Scott CR, Kishnani PS, Bali D (2006) The use of acarbose inhibition in the measurement of acid alpha-glucosidase activity in blood lymphocytes for the diagnosis of Pompe disease. Genet Med 8:307–312PubMedCrossRef
go back to reference Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D (2006) A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 148:671–676PubMedCrossRef Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D (2006) A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 148:671–676PubMedCrossRef
go back to reference Laforet P, Petiot P, Nicolino M et al (2008) Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease. Neurology 70:2063–2066PubMedCrossRef Laforet P, Petiot P, Nicolino M et al (2008) Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease. Neurology 70:2063–2066PubMedCrossRef
go back to reference Menon V, Uddin LQ (2010) Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct 214(5–6):655–667PubMedCrossRef Menon V, Uddin LQ (2010) Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct 214(5–6):655–667PubMedCrossRef
go back to reference Peyron R, Laurent B, García-Larrea L (2000) Functional imaging of brain responses to pain. A review and meta-analysis. Neurophysiol Clin 30(5):263–288PubMedCrossRef Peyron R, Laurent B, García-Larrea L (2000) Functional imaging of brain responses to pain. A review and meta-analysis. Neurophysiol Clin 30(5):263–288PubMedCrossRef
go back to reference Raben N, Plotz P, Byrne BJ (2002) Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). Curr Mol Med 2:145–166PubMedCrossRef Raben N, Plotz P, Byrne BJ (2002) Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). Curr Mol Med 2:145–166PubMedCrossRef
go back to reference Reitan RM (1955) The relation of the trail making test to organic brain damage. J Consult Psychol 19:393–394PubMedCrossRef Reitan RM (1955) The relation of the trail making test to organic brain damage. J Consult Psychol 19:393–394PubMedCrossRef
go back to reference Seeley WW, Menon V, Schatzberg AF et al (2007) Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci 27(9):2349–2356PubMedCrossRef Seeley WW, Menon V, Schatzberg AF et al (2007) Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci 27(9):2349–2356PubMedCrossRef
go back to reference Spiridigliozzi GA, Heller JH, Kishnani PS (2012) Cognitive and adaptive functioning of children with infantile Pompe disease treated with enzyme replacement therapy: long-term follow-up. Am J Med Genet C Semin Med Genet 160:22–29CrossRef Spiridigliozzi GA, Heller JH, Kishnani PS (2012) Cognitive and adaptive functioning of children with infantile Pompe disease treated with enzyme replacement therapy: long-term follow-up. Am J Med Genet C Semin Med Genet 160:22–29CrossRef
go back to reference Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643–662CrossRef Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643–662CrossRef
go back to reference Sunderland T, Hill JL, Mellow AM et al (1989) Clock drawing in Alzheimer’s disease. A novel measure of dementia severity. J Am Geriatr Soc 37:725–729PubMed Sunderland T, Hill JL, Mellow AM et al (1989) Clock drawing in Alzheimer’s disease. A novel measure of dementia severity. J Am Geriatr Soc 37:725–729PubMed
go back to reference Taksir TV, Griffiths D, Johnson J, Ryan S, Shihabuddin LS, Thurberg BL (2007) Optimized preservation of CNS morphology for the identification of glycogen in the Pompe mouse model. J Histochem Cytochem 55:991–998PubMedCrossRef Taksir TV, Griffiths D, Johnson J, Ryan S, Shihabuddin LS, Thurberg BL (2007) Optimized preservation of CNS morphology for the identification of glycogen in the Pompe mouse model. J Histochem Cytochem 55:991–998PubMedCrossRef
go back to reference Thompson PM, Martin NG, Wright MJ (2010) Imaging genomics. Curr Opin Neurol 23:368–373PubMed Thompson PM, Martin NG, Wright MJ (2010) Imaging genomics. Curr Opin Neurol 23:368–373PubMed
go back to reference van der Ploeg AT, Clemens PR, Corzo D et al (2010) A randomized study of alglucosidase alfa in late-onset Pompe’s disease. N Engl J Med 362:1396–1406PubMedCrossRef van der Ploeg AT, Clemens PR, Corzo D et al (2010) A randomized study of alglucosidase alfa in late-onset Pompe’s disease. N Engl J Med 362:1396–1406PubMedCrossRef
go back to reference van der Walt JD, Swash M, Leake J, Cox EL (1987) The pattern of involvement of adult-onset acid maltase deficiency at autopsy. Muscle Nerve 10:272–281PubMedCrossRef van der Walt JD, Swash M, Leake J, Cox EL (1987) The pattern of involvement of adult-onset acid maltase deficiency at autopsy. Muscle Nerve 10:272–281PubMedCrossRef
go back to reference Winkel LP, Hagemans ML, van Doorn PA et al (2005) The natural course of non-classic Pompe’s disease; a review of 225 published cases. J Neurol 252:875–884PubMedCrossRef Winkel LP, Hagemans ML, van Doorn PA et al (2005) The natural course of non-classic Pompe’s disease; a review of 225 published cases. J Neurol 252:875–884PubMedCrossRef
go back to reference Wokke JH, Escolar DM, Pestronk A et al (2008) Clinical features of late-onset Pompe disease: a prospective cohort study. Muscle Nerve 38:1236–1245PubMedCrossRef Wokke JH, Escolar DM, Pestronk A et al (2008) Clinical features of late-onset Pompe disease: a prospective cohort study. Muscle Nerve 38:1236–1245PubMedCrossRef
go back to reference Zhou J, Greicius MD, Gennatas ED et al (2010) Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer’s disease. Brain 133:1352–1367PubMedCrossRef Zhou J, Greicius MD, Gennatas ED et al (2010) Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer’s disease. Brain 133:1352–1367PubMedCrossRef
Metadata
Title
The brain in late-onset glycogenosis II: a structural and functional MRI study
Authors
Barbara Borroni
M. S. Cotelli
E. Premi
S. Gazzina
M. Cosseddu
A. Formenti
R. Gasparotti
M. Filosto
A. Padovani
Publication date
01-11-2013
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 6/2013
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-013-9601-7

Other articles of this Issue 6/2013

Journal of Inherited Metabolic Disease 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.